• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癣感染的治疗与预防

Treatment and prophylaxis of tinea infections.

作者信息

Piérard G E, Arrese J E, Piérard-Franchimont C

机构信息

Department of Dermatopathology, University of Liège, Belgium.

出版信息

Drugs. 1996 Aug;52(2):209-24. doi: 10.2165/00003495-199652020-00005.

DOI:10.2165/00003495-199652020-00005
PMID:8841739
Abstract

Superficial fungal infections affect millions of people throughout the world. Among them, tinea represents cutaneous infections by dermatophytes. Therapeutic strategies depend upon the affected body site. Hence, clinicians distinguish several types of tinea including the corporis, faciei, cruris, pedis, manuum, capitis, barbae and unguium variants. There are several ways of tackling the tinea problem. Numerous topical and oral antifungals are available today. Topical antifungals remain the most commonly recommended treatment for many superficial dermatophytoses. Active compounds include imidazoles, morpholines and allylamines, with a few other miscellaneous drugs. The recent development of new generation oral agents (fluconazole, itraconazole, terbinafine) has enhanced the armamentarium against difficult-to-treat tineas. The antifungal efficacy and pharmacokinetic profiles of these drugs allow shorter durations of treatment and the innovative use of intermittent pulse regimens. The modern formulations fully meet the requirements of being well tolerated, involving little risk and acting specifically against relevant pathogens. However, the response rates to date do not always come up to the high expectations offered by in vitro studies.

摘要

浅表真菌感染影响着全球数百万人。其中,癣是由皮肤癣菌引起的皮肤感染。治疗策略取决于感染的身体部位。因此,临床医生区分了几种类型的癣,包括体癣、面癣、股癣、足癣、手癣、头癣、须癣和甲癣变种。有几种方法可以解决癣的问题。如今有许多局部和口服抗真菌药物。局部抗真菌药物仍然是许多浅表皮肤癣菌病最常用的推荐治疗方法。活性化合物包括咪唑类、吗啉类和烯丙胺类,还有一些其他杂类药物。新一代口服药物(氟康唑、伊曲康唑、特比萘芬)的最新发展增强了对抗难治性癣的武器库。这些药物的抗真菌疗效和药代动力学特征允许缩短治疗时间,并创新性地使用间歇性脉冲疗法。现代制剂完全满足耐受性良好、风险小且能特异性对抗相关病原体的要求。然而,迄今为止的有效率并不总是能达到体外研究提出的高期望。

相似文献

1
Treatment and prophylaxis of tinea infections.癣感染的治疗与预防
Drugs. 1996 Aug;52(2):209-24. doi: 10.2165/00003495-199652020-00005.
2
New Antifungal Agents and New Formulations Against Dermatophytes.新型抗真菌药物和针对皮肤癣菌的新制剂。
Mycopathologia. 2017 Feb;182(1-2):127-141. doi: 10.1007/s11046-016-0045-0. Epub 2016 Aug 8.
3
Terbinafine. An update of its use in superficial mycoses.特比萘芬。其在浅表真菌病治疗中的应用进展
Drugs. 1999 Jul;58(1):179-202. doi: 10.2165/00003495-199958010-00018.
4
Common tinea infections in children.儿童常见的癣感染。
Am Fam Physician. 2008 May 15;77(10):1415-20.
5
Diagnosis and management of common tinea infections.常见癣感染的诊断与管理
Am Fam Physician. 1998 Jul;58(1):163-74, 177-8.
6
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.四种口服抗真菌药物(氟康唑、灰黄霉素、伊曲康唑和特比萘芬)在印度当前皮肤癣菌病流行中的疗效有限:一项随机实用试验的结果
Br J Dermatol. 2020 Nov;183(5):840-846. doi: 10.1111/bjd.19146. Epub 2020 Jun 15.
7
Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.口服抗真菌药物在免疫功能低下患者浅表真菌感染治疗中的作用。
Cutis. 2001 Jul;68(1 Suppl):6-14.
8
Topical antifungal drugs in the treatment of tinea pedis, tinea cruris, and tinea corporis.局部抗真菌药物治疗足癣、股癣和体癣。
J Am Acad Dermatol. 1993 May;28(5 Pt 1):S24-S28. doi: 10.1016/s0190-9622(09)80304-6.
9
Oral terbinafine: a new antifungal agent.口服特比萘芬:一种新型抗真菌剂。
Ann Pharmacother. 1997 Apr;31(4):445-56. doi: 10.1177/106002809703100412.
10
Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.伊曲康唑与灰黄霉素治疗体股癣和手足癣的比较:基于药代动力学特征对所有已完成的双盲研究临床结果的解读
Dermatology. 1992;184(1):45-50. doi: 10.1159/000247498.

引用本文的文献

1
Synergistic Effect of the Combination of Deferoxamine and Fluconazole and against Fluconazole-Resistant Spp.去铁胺与氟康唑联用对氟康唑耐药株的协同作用
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0072522. doi: 10.1128/aac.00725-22. Epub 2022 Oct 26.
2
Studies on comparison of the efficacy of terbinafine 1% cream and butenafine 1% cream for the treatment of Tinea cruris.1%特比萘芬乳膏与1%布替萘芬乳膏治疗股癣疗效比较的研究
Indian Dermatol Online J. 2010 Jul;1(1):8-9. doi: 10.4103/2229-5178.73249.
3
Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention.

本文引用的文献

1
Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption.灰黄霉素的人体药理学:脂肪摄入对胃肠道吸收的影响。
J Invest Dermatol. 1961 Dec;37:529-33. doi: 10.1038/jid.1961.154.
2
Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.特比萘芬。对其用于浅表真菌感染的药物经济学评价。
Pharmacoeconomics. 1995 Sep;8(3):253-69. doi: 10.2165/00019053-199508030-00008.
3
Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum.
儿童新发真菌感染:关于其临床表现、诊断及预防的综述
J Pharm Bioallied Sci. 2010 Oct;2(4):314-20. doi: 10.4103/0975-7406.72131.
4
Rapid detection of dermatophytes from skin and hair.从皮肤和毛发中快速检测皮肤癣菌。
BMC Res Notes. 2009 Apr 18;2:60. doi: 10.1186/1756-0500-2-60.
5
Tinea cruris in female prostitutes.女性性工作者的股癣
Mycopathologia. 2002;153(1):29-31. doi: 10.1023/a:1015257320824.
6
Current management of fungal infections.真菌感染的当前管理
Drugs. 2001;61 Suppl 1:13-25. doi: 10.2165/00003495-200161001-00002.
7
An overview of fungal infections.真菌感染概述。
Drugs. 2001;61 Suppl 1:1-12. doi: 10.2165/00003495-200161001-00001.
8
A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.用于治疗甲癣的新型口服抗真菌药物的风险效益评估。
Drug Saf. 2000 Jan;22(1):33-52. doi: 10.2165/00002018-200022010-00004.
9
Terbinafine. An update of its use in superficial mycoses.特比萘芬。其在浅表真菌病治疗中的应用进展
Drugs. 1999 Jul;58(1):179-202. doi: 10.2165/00003495-199958010-00018.
10
Butenafine.布替萘芬
Drugs. 1998 Mar;55(3):405-12; discussion 413. doi: 10.2165/00003495-199855030-00006.
一名由石膏样小孢子菌引起的甲癣患者对伊曲康唑治疗出现矛盾反应。
Ann Soc Belg Med Trop. 1995 Sep;75(3):211-7.
4
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.伊曲康唑。对其药理特性及在浅表真菌感染治疗中的应用的重新评估。
Drugs. 1996 Apr;51(4):585-620. doi: 10.2165/00003495-199651040-00006.
5
Present and potential diagnostic techniques in onychomycosis.甲真菌病的现有及潜在诊断技术
J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):273-7. doi: 10.1016/s0190-9622(96)80122-8.
6
Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy.皮肤癣菌性甲感染的治疗:一项开放性随机研究,比较间歇性特比萘芬疗法与连续性特比萘芬治疗以及间歇性伊曲康唑疗法。
J Am Acad Dermatol. 1996 Apr;34(4):595-600. doi: 10.1016/s0190-9622(96)80057-0.
7
Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis.每月一次为期一周的伊曲康唑脉冲疗法治疗甲癣三至四个月。
Cutis. 1995 Sep;56(3):180-3.
8
Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study.1%和2%艾伯康唑(WAS 2160)乳膏局部治疗体癣和股癣:一项II期剂量探索性初步研究。
Mycoses. 1995 Jul-Aug;38(7-8):317-24. doi: 10.1111/j.1439-0507.1995.tb00415.x.
9
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.甲癣的抗真菌脉冲疗法。伊曲康唑1周脉冲疗法每月周期的药代动力学和药效学研究。
Arch Dermatol. 1996 Jan;132(1):34-41. doi: 10.1001/archderm.132.1.34.
10
Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study.
Am J Nephrol. 1995;15(6):493-9. doi: 10.1159/000168892.